연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1447. Efficacy of exemestane in korean patients with metastatic breast cancer after failure of nonsteroidal aromatase inhibitors.
Lee JK1, Im SA, Lee D, Kim JY, Lim Y, Lee E, Moon HG, Kim TY, Han SW, Oh DY, Lee SH, Han W, Kim DW, Kim TY, Noh DY.
J Breast Cancer. 2013 Mar;16(1):66-71. doi: 10.4048/jbc.2013.16.1.66. Epub 2013 Mar 31.
Link
1446. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Nam HJ1, Im SA, Oh DY, Elvin P, Kim HP, Yoon YK, Min A, Song SH, Han SW, Kim TY, Bang YJ.
Mol Cancer Ther. 2013 Jan;12(1):16-26. doi: 10.1158/1535-7163.MCT-12-0109. Epub 2012 Nov 9.
Link
1445. Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery.
Jung DH1, Lee HJ, Han DS, Suh YS, Kong SH, Lee KU, Yang HK.
Gastric Cancer. 2013 Jul;16(3):377-82. doi: 10.1007/s10120-012-0196-8. Epub 2012 Sep 25.
Link
1444. Laparoscopic gastrectomy for gastric cancer.
Lee HJ1, Yang HK.
Dig Surg. 2013;30(2):132-41. doi: 10.1159/000350884. Epub 2013 Jul 18.
Link
1443. Analysis of the Lymphatic Stream to Predict Sentinel Nodes in Gastric Cancer Patients.
Lee JH1, Lee HJ, Kong SH, Park DJ, Lee HS, Kim WH, Kim HH, Yang HK.
Ann Surg Oncol. 2013 Nov 26. [Epub ahead of print]
Link
1442. Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib.
Park JH1, Kim TM, Keam B, Jeon YK, Lee SH, Kim DW, Chung DH, Kim YT, Kim YW, Heo DS.
Clin Lung Cancer. 2013 Jul;14(4):383-9. doi: 10.1016/j.cllc.2012.10.007. Epub 2013 Jan 10.
Link
1441. Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.
Kim S1, Kim TM, Kim DW, Go H, Keam B, Lee SH, Ku JL, Chung DH, Heo DS.
J Thorac Oncol. 2013 Apr;8(4):415-22. doi: 10.1097/JTO.0b013e318283dcc0.
Link
1440. Early response evaluation for recurrent high grade gliomas treated with bevacizumab: a volumetric analysis using diffusion-weighted imaging.
Hwang EJ1, Cha Y, Lee AL, Yun TJ, Kim TM, Park CK, Kim JH, Sohn CH, Park SH, Kim IH, Heo DS, Lee SH, Choi SH.
J Neurooncol. 2013 May;112(3):427-35. doi: 10.1007/s11060-013-1072-z. Epub 2013 Feb 17.
Link
1439. Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes.
Jeon Y1, Kim SY, Kim M, Park HK, Lee SH, See CJ, Kwon J, Lee DS.
Blood Cells Mol Dis. 2013 Nov 7. pii: S1079-9796(13)00237-4. doi: 10.1016/j.bcmd.2013.10.008. [Epub ahead of print]
Link
1438. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
Kim M1, Kook H, Park HJ, Ahn HS, Lee KC, Lee KS, Park SK, Lim JY, Kim HK, Han DK, Lee DS; Korean Pediatric MDS Working Party.
Acta Haematol. 2013;130(2):115-21. doi: 10.1159/000347038. Epub 2013 Apr 3.
Link